EDRH
ONC icon

Edmond de Rothschild Holding’s BeOne Medicines Ltd ONC Stock Holding History

Edmond de Rothschild Holding’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.59M Sell
33,660
-9,770
-22% -$2.88M 0.13% 136
2026
Q1 		$12.9M Buy
43,430
+10,410
+32% +$3.37M 0.19% 108
2025
Q4 		$10M Hold
33,020
– – 0.14% 130
2025
Q3 		$11.2M Sell
33,020
-7,990
-19% -$2.43M 0.17% 115
2025
Q2 		$9.93M Sell
41,010
-18,450
-31% -$4.52M 0.16% 121
2025
Q1 		$16.2M Sell
59,460
-28,830
-33% -$6.74M 0.29% 88
2024
Q4 		$16.3M Sell
88,290
-15,600
-15% -$3.19M 0.28% 90
2024
Q3 		$23.3M Buy
103,890
+11,000
+12% +$1.98M 0.38% 73
2024
Q2 		$13.3M Hold
92,890
– – 0.23% 105
2024
Q1 		$14.5M Buy
92,890
+10,900
+13% +$1.76M 0.24% 101
2023
Q4 		$14.8M Hold
81,990
– – 0.26% 96
2023
Q3 		$14.7M Buy
81,990
+25,610
+45% +$5.07M 0.3% 93
2023
Q2 		$10.1M Buy
56,380
+6,000
+12% +$1.38M 0.2% 124
2023
Q1 		$10.9M Sell
50,380
-20,520
-29% -$4.92M 0.25% 108
2022
Q4 		$15.6M Buy
70,900
+3,000
+4% +$550K 0.36% 78
2022
Q3 		$9.15M Hold
67,900
– – 0.24% 116
2022
Q2 		$11M Buy
67,900
+2,900
+4% +$453K 0.27% 112
2022
Q1 		$12.3M Buy
65,000
+13,010
+25% +$2.77M 0.27% 107
2021
Q4 		$14.1M Buy
51,990
+6,090
+13% +$2.06M 0.3% 93
2021
Q3 		$16.7M Sell
45,900
-1,320
-3% -$432K 0.39% 76
2021
Q2 		$16.2M Buy
47,220
+3,473
+8% +$1.15M 0.37% 79
2021
Q1 		$15.2M Sell
43,747
-15,797
-27% -$5.23M 0.42% 74
2020
Q4 		$15.4M Sell
59,544
-7,610
-11% -$2.1M 0.52% 60
2020
Q3 		$19.2M Sell
67,154
-7,390
-10% -$1.74M 0.76% 39
2020
Q2 		$14M Buy
74,544
+19,424
+35% +$3.16M 0.58% 49
2020
Q1 		$6.79M Buy
55,120
+25,620
+87% +$4.01M 0.36% 79
2019
Q4 		$4.89M Buy
+29,500
New +$4.9M 0.19% 120

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Edmond de Rothschild Holding's ONC Position: Q2 2026 in Review

Edmond de Rothschild Holding reduced its BeOne Medicines Ltd (ONC) stake by 22% in Q2 2026, selling an estimated $2.88M and leaving 33,660 shares worth $9.59M. The position accounts for 0.13% of the portfolio, ranked #136.

Edmond de Rothschild Holding first reported a position in ONC in Q4 2019 and has held it in 27 quarters since. The position peaked at $23.3M in Q3 2024. 283 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Edmond de Rothschild Holding held 33,660 shares of BeOne Medicines Ltd worth $9.59M as of Q2 2026.
  • Edmond de Rothschild Holding sold 9,770 BeOne Medicines Ltd shares in Q2 2026, an estimated $2.88M.
  • BeOne Medicines Ltd made up 0.13% of Edmond de Rothschild Holding's portfolio in Q2 2026, its #136 holding.
  • Edmond de Rothschild Holding first reported a position in BeOne Medicines Ltd in Q4 2019 and has held it in 27 quarters since.
  • Edmond de Rothschild Holding's BeOne Medicines Ltd position peaked at $23.3M in Q3 2024.
  • 283 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Edmond de Rothschild Holding's 13F filing for Q2 2026, filed 10 Aug 2026.